6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine t
about
Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management.A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literatureFunctional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphyComparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.Pheochromocytoma and paraganglioma: current functional and future molecular imaging.Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors.Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasMalignant pheochromocytomas and paragangliomas: a diagnostic challenge.Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.Molecular imaging of adrenal neoplasms.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typeThe incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.[Oncologic imaging: indications for and limitations of modern cross-sectional imaging techniques].Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma.Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma.Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.A case of added value of 123I-mIBG SPECT/CT imaging in the diagnosis of a pheochromocytoma extending into the left adrenal vein.Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis
P2860
Q30412504-9D8CF353-3675-41EE-92C6-4269D77D880FQ34029349-C30D12D4-60FC-491F-90FB-3923637256DBQ35198539-4FA6CBC7-C62F-4A23-89C9-621A2386D2ABQ35801361-3EF0CF76-E07C-43ED-8E0F-0EEC561A122EQ35972320-EACAC9D1-AF62-4A19-9C3A-2FCE467E42A1Q36029393-1FC00695-40D5-41E0-A8C5-F4DC4CB7D7CFQ36152379-0764C425-7B1F-460A-8DDE-FADD5D987A1DQ36167038-525DEEAA-014C-4422-80C4-BF774903C0A1Q36294179-AC864E9F-F721-4715-820F-D8646ABD0C31Q36467722-DD93ECEA-C58A-4D0C-93E2-886E13027F66Q36521985-2F4AED48-A9C2-4AC1-AC01-2498AEC9436EQ36724520-FA9C4F69-1C87-461C-9769-5EE579ABB20AQ36804496-6723CCFD-E097-4D1E-B4DD-A11D67BC1D37Q37962361-18BE9C3D-F9D1-4C2B-A77D-F0EC5293F05CQ37987448-A9E824B1-5236-45DF-9E5F-CD0D26512142Q38013072-16797039-F05B-4763-A7C1-0098540742C4Q38082417-B3290ECC-27FB-465F-BCDD-85F6220D23EAQ38348673-9E5F855B-9903-4DCE-A572-F5BC8A748637Q45350353-E13EC632-9996-49D9-B095-7C0AF88C6169Q45384072-9FE22364-3BB6-4958-A372-9A06A7B899B2Q51058465-9118970D-C2B1-425B-B4C9-2A48ED08C2F1Q52886146-19EA3ACC-BC99-49FD-8B35-ED3EA6B0B3A2Q52987280-EA67E347-7E64-4F27-9B0B-80CD2F2FC32AQ53010489-30D05E3D-FF93-4156-BA7D-CF4CF9CFC816Q58005428-C18D884E-AB81-453D-ADB3-091BFD9AA2BC
P2860
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine t
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@en
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@nl
type
label
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@en
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@nl
prefLabel
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@en
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@nl
P2093
P356
P1476
6-18F-fluoro-L-dihydroxyphenyl ...... ion with vesicular monoamine t
@en
P2093
H Rossmann
K J Lackner
M Schreckenberger
P Bartenstein
P304
P356
10.1210/JC.2009-2352
P407
P577
2010-04-06T00:00:00Z